Q-Line Biotech
Symbol: QLINE | Industry: Biotechnology & Drugs
Grey Market Premium (GMP)
GMP ACTIVE+₹135.00
Updated: Recent₹478.00
Based on Max Price: ₹343.00+39.36%
Projections onlyIPO Quick Highlights
IPO Timeline
- IPO Opens 21 May 2026
- IPO Closes 25 May 2026
- Allotment Date 26 May 2026
- Listing Date 29 May 2026
About the Company
Q-Line Biotech Ltd is engaged in the business of developing, manufacturing and marketing a diverse range of reagents (including kits and POC devices) and consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The Company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs directly or through its distributors, who in turn sell its products to hospitals/diagnostic centers or directly to diagnostic service providers and hospitals. It has developed a diversified product portfolio in the IVD industry which includes reagents, point of care devices and kits used in clinical chemistry, coagulation, hematology, HPLC, rapid/ELISA, molecular, diagnostic instruments, equipment, consumables and services. It markets these products in around 26 states and the Union Territory with specific focus on Utter Pradesh, Rajasthan, Madhya Pradesh, Kerala and Odisha.
Promoters & Key Management
| Rank | Officer Name | Designation | Age | Since |
|---|---|---|---|---|
| #1 | Meenakshi Dass | Chief Financial Officer | 60 | 2025 |
| #2 | Kuldeep Chowdhry | Whole-Time Director | 52 | 2025 |
| #3 | Ajay Kumar Mahanty | Whole-Time Director | 46 | 2025 |
| #4 | Yethadka Subraya Prabhakara | Whole-Time Director | 68 | 2025 |
| #5 | Saurabh Garg | Managing Director (Promoter) | 52 | 2025 |
Financial Performance
Values in ₹ Crores| Key Metric | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | Trend |
|---|---|---|---|---|---|---|
| Total Revenue | 608.36 | 365.47 | 407.29 | 627.56 | - | - |
| Profit After Tax (PAT) | 110.03 | 64.19 | 68.90 | 56.26 | - | - |
| Operating Margin (%) | 24.07% | 17.85% | 16.99% | 16.43% | - | - |
| Total Assets | 191.98 | 251.58 | 339.25 | 455.49 | 561.34 | - |
| Net Worth | 102.00 | 127.37 | 161.81 | 189.95 | 229.16 | - |
| Borrowings (Debt) | 43.43 | 73.65 | 96.91 | 166.29 | 243.85 | - |
| Debt to Equity Ratio | 0.43 | 0.58 | 0.60 | 0.88 | 1.06 | - |
IPO Valuation
IPO Lot Size Details
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Minimum) | 1 Lot | 1 Shares | ₹343.00 |
| Retail (Maximum) | 583 Lots | 583 Shares | ₹199,969.00 |
| Small HNI (sNII - Min) | 584 Lots | 584 Shares | ₹200,312.00 |
| Small HNI (sNII - Max) | 2915 Lots | 2915 Shares | ₹999,845.00 |
| Big HNI (bNII - Min) | 2916 Lots | 2916 Shares | ₹1,000,188.00 |
